Microbial lipid

Microbial lipids represent a diverse class of essential structural and signaling molecules found in the cell envelopes of bacteria and fungi, serving as critical targets for several major classes of antimicrobial drugs. This target group includes specific molecules such as ergosterol, the primary sterol in fungal membranes; Lipid II, an essential lipid-linked precursor for bacterial peptidoglycan synthesis; and Lipid A, the endotoxic hydrophobic anchor of lipopolysaccharides in Gram-negative bacteria. Therapeutic agents like polyene antifungals, polymyxins, and glycopeptides exert their effects by directly binding to these lipids, which leads to membrane pore formation, leakage of intracellular contents, or the inhibition of cell wall assembly. Because many of these lipids are structurally distinct from human lipids (such as cholesterol), they provide a high degree of selectivity for treating infections. However, targeting these molecules can be associated with significant clinical challenges, including nephrotoxicity and the risk of triggering systemic inflammatory responses when large amounts of endotoxic lipids are released during treatment. In addition to their role as drug targets, microbial lipids act as potent antigens that are recognized by the host's innate and adaptive immune systems, particularly through specialized molecules like CD1.

Other names

Microbial membrane lipidBacterial lipidFungal lipidLipid IILipid AErgosterolPeptidoglycan precursor lipid

Drugs targeting microbial lipids primarily act through direct physical binding to the target molecule, which either disrupts the integrity of the microbial cell membrane (leading to pore formation and ion leakage) or sequesters essential biosynthetic precursors to arrest cell wall assembly.